Hollister-Stier Laboratories (TwinJect Rights)

Hollister-Stier Laboratories (TwinJect Rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 2

Hollister-Stier Laboratories (TwinJect Rights) General Information

Description

An emergency supportive therapy used for the treatment of severe allergic reactions and anaphylaxis.The product is designed as an emergency supportive therapy for immediate treatment of Anaphylaxis which is a sudden, severe, and potentially life-threatening allergic reaction triggered by exposure to one or more allergens, including foods, insect stings, drugs, and latex products and is indicated in the emergency treatment of this severe allergic reaction.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Spokane, WA
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hollister-Stier Laboratories (TwinJect Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hollister-Stier Laboratories (TwinJect Rights)‘s full profile, request access.

Request a free trial

Hollister-Stier Laboratories (TwinJect Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hollister-Stier Laboratories (TwinJect Rights)‘s full profile, request access.

Request a free trial